A citation-based method for searching scientific literature

Jian P Gong, Stephanie Schulz, Terry Hyslop, Scott A Waldman. Biomark Med 2012
Times Cited: 3







List of co-cited articles
7 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Chimeric antigen receptor T cells for sustained remissions in leukemia.
Shannon L Maude, Noelle Frey, Pamela A Shaw, Richard Aplenc, David M Barrett, Nancy J Bunin, Anne Chew, Vanessa E Gonzalez, Zhaohui Zheng, Simon F Lacey,[...]. N Engl J Med 2014
66

Current concepts in the diagnosis and management of cytokine release syndrome.
Daniel W Lee, Rebecca Gardner, David L Porter, Chrystal U Louis, Nabil Ahmed, Michael Jensen, Stephan A Grupp, Crystal L Mackall. Blood 2014
66

Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer.
Glen S Frick, Giovanni M Pitari, David S Weinberg, Terry Hyslop, Stephanie Schulz, Scott A Waldman. Expert Rev Mol Diagn 2005
50
66

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2.
Richard A Morgan, James C Yang, Mio Kitano, Mark E Dudley, Carolyn M Laurencot, Steven A Rosenberg. Mol Ther 2010
66

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells.
James N Kochenderfer, Mark E Dudley, Steven A Feldman, Wyndham H Wilson, David E Spaner, Irina Maric, Maryalice Stetler-Stevenson, Giao Q Phan, Marybeth S Hughes, Richard M Sherry,[...]. Blood 2012
977
66

Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.
Marco L Davila, Isabelle Riviere, Xiuyan Wang, Shirley Bartido, Jae Park, Kevin Curran, Stephen S Chung, Jolanta Stefanski, Oriana Borquez-Ojeda, Malgorzata Olszewska,[...]. Sci Transl Med 2014
66

GUCY2C-targeted cancer immunotherapy: past, present and future.
Adam E Snook, Michael S Magee, Scott A Waldman. Immunol Res 2011
8
66

AMPKα modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancer.
Yon Hui Kim, Han Liang, Xiuping Liu, Ju-Seog Lee, Jae Yong Cho, Jae-Ho Cheong, Hoguen Kim, Min Li, Thomas J Downey, Matthew D Dyer,[...]. Cancer Res 2012
72
33

A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition.
Steven R Whittaker, Jean-Philippe Theurillat, Eliezer Van Allen, Nikhil Wagle, Jessica Hsiao, Glenn S Cowley, Dirk Schadendorf, David E Root, Levi A Garraway. Cancer Discov 2013
225
33


BRAF alterations are associated with complex mutational profiles in malignant melanoma.
Maria Daniotti, Maria Oggionni, Tiziana Ranzani, Viviana Vallacchi, Valentina Campi, Delia Di Stasi, Gabriella Della Torre, Federica Perrone, Chiara Luoni, Simona Suardi,[...]. Oncogene 2004
149
33

Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing.
Mitchell S Stark, Susan L Woods, Michael G Gartside, Vanessa F Bonazzi, Ken Dutton-Regester, Lauren G Aoude, Donald Chow, Chris Sereduk, Natalie M Niemi, Nanyun Tang,[...]. Nat Genet 2011
137
33

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.
Satoru Yokoyama, Susan L Woods, Glen M Boyle, Lauren G Aoude, Stuart MacGregor, Victoria Zismann, Michael Gartside, Anne E Cust, Rizwan Haq, Mark Harland,[...]. Nature 2011
263
33

Predicting the functional impact of protein mutations: application to cancer genomics.
Boris Reva, Yevgeniy Antipin, Chris Sander. Nucleic Acids Res 2011
33

A landscape of driver mutations in melanoma.
Eran Hodis, Ian R Watson, Gregory V Kryukov, Stefan T Arold, Marcin Imielinski, Jean-Philippe Theurillat, Elizabeth Nickerson, Daniel Auclair, Liren Li, Chelsea Place,[...]. Cell 2012
33

Exome sequencing identifies GRIN2A as frequently mutated in melanoma.
Xiaomu Wei, Vijay Walia, Jimmy C Lin, Jamie K Teer, Todd D Prickett, Jared Gartner, Sean Davis, Katherine Stemke-Hale, Michael A Davies, Jeffrey E Gershenwald,[...]. Nat Genet 2011
352
33

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.
Manabu Soda, Young Lim Choi, Munehiro Enomoto, Shuji Takada, Yoshihiro Yamashita, Shunpei Ishikawa, Shin-ichiro Fujiwara, Hideki Watanabe, Kentaro Kurashina, Hisashi Hatanaka,[...]. Nature 2007
33

Chromosomal localization of genes encoding guanine nucleotide-binding protein subunits in mouse and human.
C Blatt, P Eversole-Cire, V H Cohn, S Zollman, R E Fournier, L T Mohandas, M Nesbitt, T Lugo, D T Jones, R R Reed. Proc Natl Acad Sci U S A 1988
112
33

NGS catalog: A database of next generation sequencing studies in humans.
Junfeng Xia, Qingguo Wang, Peilin Jia, Bing Wang, William Pao, Zhongming Zhao. Hum Mutat 2012
23
33

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.
Michael Krauthammer, Yong Kong, Byung Hak Ha, Perry Evans, Antonella Bacchiocchi, James P McCusker, Elaine Cheng, Matthew J Davis, Gerald Goh, Murim Choi,[...]. Nat Genet 2012
763
33

A comprehensive catalogue of somatic mutations from a human cancer genome.
Erin D Pleasance, R Keira Cheetham, Philip J Stephens, David J McBride, Sean J Humphray, Chris D Greenman, Ignacio Varela, Meng-Lay Lin, Gonzalo R Ordóñez, Graham R Bignell,[...]. Nature 2010
33

Understanding the contribution of synonymous mutations to human disease.
Zuben E Sauna, Chava Kimchi-Sarfaty. Nat Rev Genet 2011
521
33

Role of TRPM in melanocytes and melanoma.
Huazhang Guo, John Andrew Carlson, Andrzej Slominski. Exp Dermatol 2012
52
33

Patterns of somatic mutation in human cancer genomes.
Christopher Greenman, Philip Stephens, Raffaella Smith, Gillian L Dalgliesh, Christopher Hunter, Graham Bignell, Helen Davies, Jon Teague, Adam Butler, Claire Stevens,[...]. Nature 2007
33

SpliceDisease database: linking RNA splicing and disease.
Juan Wang, Jie Zhang, Kaibo Li, Wei Zhao, Qinghua Cui. Nucleic Acids Res 2012
35
33

Frequent alterations in the expression of serine/threonine kinases in human cancers.
Maria Capra, Paolo Giovanni Nuciforo, Stefano Confalonieri, Micaela Quarto, Marco Bianchi, Manuela Nebuloni, Renzo Boldorini, Francesco Pallotti, Giuseppe Viale, Mikhail L Gishizky,[...]. Cancer Res 2006
105
33

Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials.
Christine M Lovly, Kimberly Brown Dahlman, Laurel E Fohn, Zengliu Su, Dora Dias-Santagata, Donna J Hicks, Donald Hucks, Elizabeth Berry, Charles Terry, MarKeesa Duke,[...]. PLoS One 2012
136
33

Eph receptors and their ligands: promising molecular biomarkers and therapeutic targets in prostate cancer.
Jessica E Lisle, Inga Mertens-Walker, Raphael Rutkowski, Adrian C Herington, Sally-Anne Stephenson. Biochim Biophys Acta 2013
26
33

Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi.
Catherine D Van Raamsdonk, Vladimir Bezrookove, Gary Green, Jürgen Bauer, Lona Gaugler, Joan M O'Brien, Elizabeth M Simpson, Gregory S Barsh, Boris C Bastian. Nature 2009
923
33

STK31 maintains the undifferentiated state of colon cancer cells.
Kin Lam Fok, Chin Man Chung, Shao Qiong Yi, Xiaohua Jiang, Xiao Sun, Hao Chen, Yang Chao Chen, Hsiang-Fu Kung, Qian Tao, Ruiying Diao,[...]. Carcinogenesis 2012
19
33

Molecular testing in melanoma.
Melissa Ann Wilson, Katherine L Nathanson. Cancer J 2012
14
33

Delving into somatic variation in sporadic melanoma.
Vijay Walia, Euphemia W Mu, Jimmy C Lin, Yardena Samuels. Pigment Cell Melanoma Res 2012
24
33

Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma.
Sergey I Nikolaev, Donata Rimoldi, Christian Iseli, Armand Valsesia, Daniel Robyr, Corinne Gehrig, Keith Harshman, Michel Guipponi, Olesya Bukach, Vincent Zoete,[...]. Nat Genet 2011
275
33

Malignant melanoma: genetics and therapeutics in the genomic era.
Lynda Chin, Levi A Garraway, David E Fisher. Genes Dev 2006
362
33

The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma.
Elisa Oricchio, Gouri Nanjangud, Andrew L Wolfe, Jonathan H Schatz, Konstantinos J Mavrakis, Man Jiang, Xiaoping Liu, Joanne Bruno, Adriana Heguy, Adam B Olshen,[...]. Cell 2011
125
33

From genes to drugs: targeted strategies for melanoma.
Keith T Flaherty, F Stephen Hodi, David E Fisher. Nat Rev Cancer 2012
260
33

Phosphorylation of BRAF by AMPK impairs BRAF-KSR1 association and cell proliferation.
Che-Hung Shen, Ping Yuan, Rolando Perez-Lorenzo, Yaqing Zhang, Sze Xian Lee, Yang Ou, John M Asara, Lewis C Cantley, Bin Zheng. Mol Cell 2013
91
33

Cancer statistics, 2013.
Rebecca Siegel, Deepa Naishadham, Ahmedin Jemal. CA Cancer J Clin 2013
33

Mutations in GNA11 in uveal melanoma.
Catherine D Van Raamsdonk, Klaus G Griewank, Michelle B Crosby, Maria C Garrido, Swapna Vemula, Thomas Wiesner, Anna C Obenauf, Werner Wackernagel, Gary Green, Nancy Bouvier,[...]. N Engl J Med 2010
853
33

Advances in understanding cancer genomes through second-generation sequencing.
Matthew Meyerson, Stacey Gabriel, Gad Getz. Nat Rev Genet 2010
726
33

Melanoma genome sequencing reveals frequent PREX2 mutations.
Michael F Berger, Eran Hodis, Timothy P Heffernan, Yonathan Lissanu Deribe, Michael S Lawrence, Alexei Protopopov, Elena Ivanova, Ian R Watson, Elizabeth Nickerson, Papia Ghosh,[...]. Nature 2012
489
33

Mutational and functional analysis reveals ADAMTS18 metalloproteinase as a novel driver in melanoma.
Xiaomu Wei, Todd D Prickett, Cristina G Viloria, Alfredo Molinolo, Jimmy C Lin, Isabel Cardenas-Navia, Pedro Cruz, Steven A Rosenberg, Michael A Davies, Jeffrey E Gershenwald,[...]. Mol Cancer Res 2010
36
33

Efficient identification of a novel cancer/testis antigen for immunotherapy using three-step microarray analysis.
Takeshi Yokoe, Fumiaki Tanaka, Koshi Mimori, Hiroshi Inoue, Takahiro Ohmachi, Masato Kusunoki, Masaki Mori. Cancer Res 2008
34
33


Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.
Eunice L Kwak, Yung-Jue Bang, D Ross Camidge, Alice T Shaw, Benjamin Solomon, Robert G Maki, Sai-Hong I Ou, Bruce J Dezube, Pasi A Jänne, Daniel B Costa,[...]. N Engl J Med 2010
33

BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition.
Katherine E Hutchinson, Doron Lipson, Philip J Stephens, Geoff Otto, Brian D Lehmann, Pamela L Lyle, Cindy L Vnencak-Jones, Jeffrey S Ross, Jennifer A Pietenpol, Jeffrey A Sosman,[...]. Clin Cancer Res 2013
106
33


Cancer driver mutations in protein kinase genes.
Ali Torkamani, Gennady Verkhivker, Nicholas J Schork. Cancer Lett 2009
63
33

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.
Doron Lipson, Marzia Capelletti, Roman Yelensky, Geoff Otto, Alex Parker, Mirna Jarosz, John A Curran, Sohail Balasubramanian, Troy Bloom, Kristina W Brennan,[...]. Nat Med 2012
578
33

Rare BRAF mutations in melanoma patients: implications for molecular testing in clinical practice.
L Heinzerling, S Kühnapfel, D Meckbach, M Baiter, E Kaempgen, P Keikavoussi, G Schuler, A Agaimy, J Bauer, A Hartmann,[...]. Br J Cancer 2013
62
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.